Generali Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.06M Buy
9,191
+2,357
+34% +$587K 0.04% 289
2025
Q4
$1.65M Sell
6,834
-2,412
-26% -$617K 0.03% 341
2025
Q3
$2.53M Sell
9,246
-769
-8% -$210K 0.05% 258
2025
Q2
$2.58M Sell
10,015
-2,680
-21% -$639K 0.06% 261
2025
Q1
$2.84M Sell
12,695
-5,653
-31% -$1.32M 0.07% 249
2024
Q4
$4.2M Buy
+18,348
New +$4.42M 0.11% 184

Other funds holding RMD

Generali Asset Management's RMD Position: Q1 2026 in Review

Generali Asset Management increased its ResMed (RMD) stake by 34% in Q1 2026, buying an estimated $587K and bringing the position to 9,191 shares worth $2.06M. The position accounts for 0.04% of the portfolio, ranked #289.

Generali Asset Management first reported a position in RMD in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.2M in Q4 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Generali Asset Management held 9,191 shares of ResMed worth $2.06M as of Q1 2026.
  • Generali Asset Management bought 2,357 ResMed shares in Q1 2026, an estimated $587K.
  • ResMed made up 0.04% of Generali Asset Management's portfolio in Q1 2026, its #289 holding.
  • Generali Asset Management first reported a position in ResMed in Q4 2024 and has held it in 6 quarters since.
  • Generali Asset Management's ResMed position peaked at $4.2M in Q4 2024.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Generali Asset Management's 13F filing for Q1 2026, filed 5 May 2026.